Find Your Funding Opportunity
Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional)
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
10-22-2025 | N/A | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Opportunity Type Discretionary
-
CFDA
93.838 -- Lung Diseases Research
Description
The National Heart, Lung and Blood Institute (NHLBI) seeks to advance its mission by supporting a consortium to phenotype 0-2 year old children with severe viral lower respiratory tract infections (LRTI) with follow up until pre-school age for pulmonary sequelae.NHLBI intends to utilize the paired activity codes U24 to fund the Data and Analytics Co-ordinating Center (DACC, FOR-25-033) and the linked UG3/UH3 (Phased award with built-in milestones for transition, FOR-HL-25-032) to fund one Clinical Coordinating Center (CCC) and Biorepository along with four Clinical Centers (CCs).
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.This NOFO will utilize the UG3/UH3 activity code. Investigators with expertise and insights into this area are encouraged to begin to consider applying for this NOFO. Grant authorities that allow NHLBIto forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Key Date(s)
- July 08, 2025: Last Updated Date
- July 08, 2025: Forecasted Date
- August 22, 2025: Estimated Post Date
- October 22, 2025: Estimated Application Due Date
- May 01, 2026: Estimated Award Date
- July 01, 2026: Estimated Project Start Date